This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stroke, Volume 56, Issue Suppl_1 , Page ATP140-ATP140, February 1, 2025. Moreover, it is unclear what effective therapeutic targets as well as molecular systemic changes in stroke in the chronic phase. Moreover, it is unclear what effective therapeutic targets as well as molecular systemic changes in stroke in the chronic phase.
Stroke, Volume 56, Issue Suppl_1 , Page AWP230-AWP230, February 1, 2025. Hemorrhagic strokes (HS) are increasingly significant causes of disability and mortality worldwide, making the use of blood biomarkers for their diagnosis and prognosis critical.
Stroke, Volume 56, Issue Suppl_1 , Page AWP396-AWP396, February 1, 2025. Pre-clinical rodent studies have identified angiopoietins, their subvariants, and receptor Tie2 in regulating collateral function and vascular remodeling following ischemic stroke.
Stroke, Volume 56, Issue Suppl_1 , Page A33-A33, February 1, 2025. Introduction:Net water uptake (NWU) is a novel biomarker which measures edema and tissue injury from the degree of hypoattenuation on non-contrast CT and may serve as a precision tool for predicting outcomes after acute ischemic stroke (AIS).
Stroke, Volume 56, Issue Suppl_1 , Page AWP88-AWP88, February 1, 2025. Background:The effect of renal dysfunction on early infarct growth rate (IGR) in anterior circulation large vessel occlusion (ACLVO) stroke is not well studied. mg/dL, p < 0.05) and lower median eGFR (66.2 mL/min/1.73m2, p < 0.05).
Stroke, Volume 56, Issue Suppl_1 , Page A146-A146, February 1, 2025. Introduction:Patients with transient ischemic attack (TIA) and those with stroke mimics (MIM) are often difficult to distinguish in emergency room (ER) settings. While TIA patients are at an increased risk of stroke, MIM do not need stroke-related management.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP101-AWMP101, February 1, 2025. It remains unclear if the biomarkers used in the trial reliably identified atrial cardiopathy. It remains unclear if the biomarkers used in the trial reliably identified atrial cardiopathy. and Canada. and Canada.
Stroke, Volume 56, Issue Suppl_1 , Page AWP359-AWP359, February 1, 2025. Background:Mechanical thrombectomy has been associated with improved outcomes in patients with acute ischemic stroke. Investigating the post-reperfusion inflammatory milieu could provide valuable insights into the mechanisms that influence stroke outcomes.
Stroke, Volume 56, Issue Suppl_1 , Page ATMP1-ATMP1, February 1, 2025. A cerebral aneurysm (CA) is an abnormal artery deformation in the brain that may lead to hemorrhagic stroke, brain damage, coma, and even death when a CA ruptures. We hypothesized that increasing CA sample size will allow more robust biomarker identification.
Stroke, Volume 56, Issue Suppl_1 , Page ATP341-ATP341, February 1, 2025. Introduction:Peripheral blood-based biomarker development for neurological diseases such as ischemic stroke has traditionally focused on measuring alterations in leukocyte number and composition. This difference was more pronounced among females.
Stroke, Volume 56, Issue Suppl_1 , Page ATP44-ATP44, February 1, 2025. However, no effective serum biomarker has been established for early diagnosis or prediction of the disease progression. However, no effective serum biomarker has been established for early diagnosis or prediction of the disease progression.
Stroke, Volume 56, Issue Suppl_1 , Page ATP49-ATP49, February 1, 2025. Background:Small vessel cerebral vascular disease (sCVD) is common to older individuals, often asymptomatic, but associated with incident stroke and future mortality. years of education. Future work will associate these findings with sCVD phenotypes.
Stroke, Volume 56, Issue Suppl_1 , Page AWP227-AWP227, February 1, 2025. Early intervention has been shown to improve patient prognosis, highlighting the necessity of sensitive biomarkers. These biomarkers could facilitate timely interventions, potentially improving outcomes for stroke patients.
Stroke, Volume 56, Issue Suppl_1 , Page AWP35-AWP35, February 1, 2025. Finally, as neutrophil counts (and the ratio of neutrophils to lymphocytes) are reported to be a biomarker for DCI, we assessed these measures too. Neutrophils are reported to be critical mediators of to poor outcome after subarachnoid hemorrhage (SAH).
Stroke, Volume 56, Issue Suppl_1 , Page ADP16-ADP16, February 1, 2025. Introduction:The National Institutes of Health Stroke Scale (NIHSS) provides a clinical measure of stroke severity. We collected blood from each patient at hospital admission before administering any therapeutic intervention.
Stroke, Volume 56, Issue Suppl_1 , Page ATP377-ATP377, February 1, 2025. Timely and accurate risk stratification of IAs is paramount.Objective:Aneurysm wall enhancement (AWE) is a potential imaging biomarker for risk stratification.
Stroke, Volume 56, Issue Suppl_1 , Page AWP6-AWP6, February 1, 2025. Background and Purpose:Whether imaging markers of cerebral small vessel disease on computed tomography (CT-CSVD) relates to early clinical outcomes after intravenous thrombolysis for acute ischemic stroke remains not well understood. 1.95, p = 0.019).Conclusion:This
Stroke, Volume 56, Issue Suppl_1 , Page A74-A74, February 1, 2025. There is a need for surrogate imaging biomarkers that more strongly associate with functional outcome, to refine prognostication and facilitate development of EVT-adjuvant neuroprotective therapies. MRI was performed 1248 hours post-EVT.
Stroke, Volume 56, Issue Suppl_1 , Page ATP320-ATP320, February 1, 2025. The alterations in this pathway have been confirmed in psychiatric disorders, but their role in stroke remains unclear. The alterations in this pathway have been confirmed in psychiatric disorders, but their role in stroke remains unclear.
Stroke, Volume 56, Issue Suppl_1 , Page ATP385-ATP385, February 1, 2025. Emerging research suggests that Vitamin D3 might help protect against brain damage caused by ischemic stroke, as a deficiency in Vitamin D3 can worsen the severity and outcomes of a stroke.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP79-AWMP79, February 1, 2025. Background and Purpose:The inflammatory response after ischemic and hemorrhagic stroke is associated with worse clinical outcomes through immune mediated production of pro- inflammatory cytokines. Of 25 enrolled patients, mean age was 65.8 (SD,
Stroke, Volume 56, Issue Suppl_1 , Page AWP272-AWP272, February 1, 2025. However, there are no existing data supporting an independent relationship between cancer and atrial cardiopathy, another atrial pathology associated with increased acute ischemic stroke (AIS) risk.
Stroke, Volume 56, Issue Suppl_1 , Page A47-A47, February 1, 2025. Introduction:The rapid identification of acute intracerebral hemorrhage (ICH) in patients with symptoms of acute stroke is decisive for prehospital triage and initiation of targeted therapies. Blood samples were collected in the prehospital phase.
Stroke, Volume 56, Issue Suppl_1 , Page AWP20-AWP20, February 1, 2025. This study aims to investigate whether RIC affects RBC deformability and levels of NO and nitrite in ischemic stroke patients.Methods:This is a predefined sub-study to the RESIST randomized clinical trial. median fluorescence intensity[MFI], Sham: 34.98
Stroke, Volume 56, Issue Suppl_1 , Page A14-A14, February 1, 2025. Funding:The INSIGHT Registry is funded by Penumbra.Introduction:Rapid and precise determination of the etiology of acute ischemic stroke is crucial in long-term management and prevention of recurrence.
Stroke, Volume 56, Issue Suppl_1 , Page AWP387-AWP387, February 1, 2025. Background:Metabolomics is commonly used to search for acute ischemic stroke (AIS) biomarkers. However, many studies which found metabolite - AIS associations have contradictory findings, which prevents solid conclusion.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP42-AWMP42, February 1, 2025. Background:The Medical Research Council (MRC) scale is used to assess the impact of stroke on muscle strength. Shoulder abduction and finger extension, collectively (SAFE), have been suggested to have prognostic value for stroke outcomes (e.g.
Stroke, Volume 56, Issue Suppl_1 , Page AWP338-AWP338, February 1, 2025. Introduction:Extracranial carotid artery pathology accounts for 15-20% of ischemic strokes. Furthermore, these patients could benefit from early surgical intervention if these biomarkers were to be detected.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP105-AWMP105, February 1, 2025. Introduction:Accurate prediction of the risk of ischemic stroke (IS) is vital for prevention and would be aided by multimodal biomarkers integrating genetic, clinical, and functional data.
Stroke, Volume 56, Issue Suppl_1 , Page ATMP25-ATMP25, February 1, 2025. Introduction:Glial fibrillary acidic protein (GFAP), highly brain-specific, is emerging as an attractive blood biomarker in acute stroke. from onset, and 28% were wake-up strokes. 24h), and ASPECTS score (8-10 vs. <8).Results:Among
Stroke, Volume 56, Issue Suppl_1 , Page ATP268-ATP268, February 1, 2025. Introduction:Xylitol, a sugar alcohol with a global market estimated at 161,500 metric tons, has been linked to increased thrombosis and risk of stroke and heart attack.
Stroke, Volume 56, Issue Suppl_1 , Page AWP226-AWP226, February 1, 2025. Specific biomarkers of platelet activity would improve our understanding of HE and could point towards targeted treatments. Globus New Investigator Award in Stroke aspirin, NSAIDs) is associated with increased HE.
Stroke, Volume 56, Issue Suppl_1 , Page AWP318-AWP318, February 1, 2025. Background:Approximately 50% of ischemic strokes in patients with cancer are classified as cryptogenic after standard evaluation. Enrolled patients consented to screening for atrial cardiopathy, the presence of which was required for randomization.
Stroke, Volume 56, Issue Suppl_1 , Page ATP209-ATP209, February 1, 2025. This workflow, which involves downloading imaging data from a clinical trials electronic data capture (EDC) system, performing biomarker analyses, and then re-entering data into the EDC, can be cumbersome when performed manually.
Stroke, Volume 56, Issue Suppl_1 , Page AWP224-AWP224, February 1, 2025. Background:The astroglial protein GFAP (glial fibrillary acidic protein) is a promising biomarker candidate for prehospital differentiation between intracerebral hemorrhage (ICH) and ischemic stroke.
Stroke, Volume 56, Issue Suppl_1 , Page ADP54-ADP54, February 1, 2025. Background:Randomized trials and observational of patients with cervical artery dissection showed no significant difference in ischemic stroke risk with anticoagulation versus antiplatelet therapy. The outcome was ischemic stroke during follow up.
Stroke, Volume 56, Issue Suppl_1 , Page AWP370-AWP370, February 1, 2025. Previous studies have identified numerous biomarkers, such as coagulation and platelet factors, which may predict patients at-risk for DCI, but to-date, no markers are widely utilized in the clinical setting.
Stroke, Volume 56, Issue Suppl_1 , Page AWP397-AWP397, February 1, 2025. Backgrounds:Our prior work demonstrated the upregulation of miR-200 family miRNAs specifically miR-141&miR-200c after stroke in mice models. The inhibition of miR-141/200c restored the levels ofTgf2, Smad2&Zeb1.Conclusion:Cluster
Stroke, Volume 56, Issue Suppl_1 , Page AWP232-AWP232, February 1, 2025. Conclusion:Spot sign visualized in conventional vascular imaging is a highly specific radiological biomarker for predicting mortality and poor functional outcomes in patients with ICH. For poor functional outcomes, OR was 4.13 (95% CI: 3.15-5.42;I2=33%).Conclusion:Spot
Stroke, Volume 56, Issue Suppl_1 , Page AWMP97-AWMP97, February 1, 2025. At baseline, DTI-ALPS was significantly correlated with PSQI (r = -0.174, p = 0.005) and various imaging biomarkers of CSVD after adjusting for age, gender, vascular risk factors, and ApoE4.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP16-AWMP16, February 1, 2025. The quantified biomarker of this pattern can be used to monitor the decline in cognitive function. Pseudocontinuous arterial spin labeling imaging was used to identify hypoperfused regions (HypoR) in the discovery cohort.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content